Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Treatment of epistaxis in Rendu-Osler-Weber disease by in situ Ethibloc injections Roux-Vaillard S; Pasco-Papon A; Laccourreye L; Dubin JJ Neuroradiol 2004[Mar]; 31 (2): 110-5After a brief review of Rendu-Osler-Weber disease, we present the results from a series of 13 patients treated by Ethibloc injections for epistaxis. Based on a review of the literature, typical treatments are presented along with discussion of their efficacy and side effects. In our series, 90% of patients improved after only one injection. All patients reported a decrease in hemorrhage, especially patients with recurrent epistaxis. Five of nine patients reported a decrease in the length of the bleeding episodes. Improvement was reported by 85% of patients within one month following Ethibloc injection. Fifty percent of these patients have persistent good results at 4 Year follow-up. Our results indicate that Ethibloc injections are safe and effective as an alternative treatment for patients that have failed standard treatment options.|Adult[MESH]|Aged[MESH]|Diatrizoate/*therapeutic use[MESH]|Drug Combinations[MESH]|Epistaxis/*drug therapy[MESH]|Fatty Acids/*therapeutic use[MESH]|Female[MESH]|Humans[MESH]|Injections[MESH]|Male[MESH]|Middle Aged[MESH]|Propylene Glycols/*therapeutic use[MESH]|Retrospective Studies[MESH]|Sclerosing Solutions/*therapeutic use[MESH]|Telangiectasia, Hereditary Hemorrhagic/*drug therapy[MESH]|Treatment Outcome[MESH]|Zein/*therapeutic use[MESH] |
